Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer.
暂无分享,去创建一个
M. Hatt | D. Groheux | P. Merlet | M. Espié | E. Hindié | A. de Roquancourt | M. Marty | P. de Cremoux | S. Giacchetti | A. Hamy | F. Berger